Trial intelligence / Profile preview

HKT-500 in mild to moderate knee osteoarthritis pain

NCT00647231Phase 2Completed

Sponsor
Hisamitsu Pharmaceutical Co., Inc.
Start
Mar 2008
Primary completion
Aug 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Ketofen in osteoarthritis (OA), sponsored by Hisamitsu Pharmaceutical Co., Inc.. Started Mar 2008; status: completed.

02

Drugs

Ketofen
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT00647231.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00647231.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call